• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非透析慢性肾脏病患者的肾性贫血与水化状态:二者有关联吗?

Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?

作者信息

Hildegard Stancu Simona, Stanciu Ana, Lipan Mariana, Capusa Cristina

机构信息

"Carol Davila" University of Medicine and Pharmacy, Nephrology Dept., Bucharest, Romania.

"Dr. Carol Davila" Teaching Hospital of Nephrology, Bucharest, Romania.

出版信息

J Med Life. 2018 Oct-Dec;11(4):293-298. doi: 10.25122/jml-2019-0002.

DOI:10.25122/jml-2019-0002
PMID:30894885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6418336/
Abstract

Anemia, a common feature in chronic kidney disease (CKD), has multiple contributors to its pathogenesis. Besides the well recognized erythropoietin and iron deficiencies, hydration status might be involved. To assess the prevalence and correlations of anemia, iron deficiency and overhydration in patients with stage 2 to 5 CKD. This cross-sectional study enrolled 125 erythropoietin and iron therapy naïve non-dialysis CKD patients, without a identifiable cause of anemia. Parameters of hematological, iron, inflammatory and nutritional status were measured. The overhydration parameter (OH) assessed by bioimpedance spectroscopy was used to characterize hydration status. The prevalence of decreased hemoglobin (Hb) <110g/L increased along CKD stages from 0% to 40% (=0.008). Fluid overload (OH >1L) and lower serum albumin (<40g/L) were more common in stage 5 versus stage 3 CKD (53% vs. 10%, <0.001, and 27% vs. 3%, =0.02, respectively), suggesting a potential dilutional reduction in serum proteins. Conversely, decreased iron stores (ferritin <100mcg/L) and iron availability (transferrin saturation, TSAT<0.20) were similarly prevalent irrespective of kidney function decline. Hemoglobin was positively correlated with estimated glomerular filtration rate (eGFR), serum albumin, and transferrin saturation, but inversely with OH. However, in a model of multiple linear regression which explained 32% of hemoglobin variation, only eGFR and overhydration remained the independent predictors of anemia. As fluid overload is a common denominator for hemoglobin and TSAT levels, and is closely related to the declining kidney function, it should be considered in the management of renal anemia, at least in advanced CKD.

摘要

贫血是慢性肾脏病(CKD)的常见特征,其发病机制有多种因素。除了众所周知的促红细胞生成素和铁缺乏外,水合状态可能也与之有关。为评估2至5期CKD患者贫血、缺铁和水合过度的患病率及相关性。这项横断面研究纳入了125例未接受促红细胞生成素和铁治疗的非透析CKD患者,且无明确的贫血病因。测量了血液学、铁、炎症和营养状态参数。采用生物电阻抗光谱法评估的水合过度参数(OH)来表征水合状态。血红蛋白(Hb)<110g/L的患病率随CKD分期增加,从0%增至40%(P=0.008)。与3期CKD相比,5期CKD患者中液体超负荷(OH>1L)和血清白蛋白降低(<40g/L)更为常见(分别为53%对10%,P<0.001,以及27%对3%,P=0.02),提示血清蛋白可能存在稀释性降低。相反,无论肾功能下降情况如何,铁储备降低(铁蛋白<100mcg/L)和铁利用率(转铁蛋白饱和度,TSAT<0.20)的患病率相似。血红蛋白与估计肾小球滤过率(eGFR)、血清白蛋白和转铁蛋白饱和度呈正相关,但与OH呈负相关。然而,在一个解释了32%血红蛋白变异的多元线性回归模型中,只有eGFR和水合过度仍是贫血的独立预测因素。由于液体超负荷是血红蛋白和TSAT水平的共同因素,且与肾功能下降密切相关,因此在肾性贫血的管理中应予以考虑,至少在晚期CKD中如此。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34b/6418336/a6dc940a8ebf/JMedLife-11-293-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34b/6418336/81d599677fad/JMedLife-11-293-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34b/6418336/f9d17a6cc937/JMedLife-11-293-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34b/6418336/a6dc940a8ebf/JMedLife-11-293-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34b/6418336/81d599677fad/JMedLife-11-293-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34b/6418336/f9d17a6cc937/JMedLife-11-293-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f34b/6418336/a6dc940a8ebf/JMedLife-11-293-g003.jpg

相似文献

1
Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?非透析慢性肾脏病患者的肾性贫血与水化状态:二者有关联吗?
J Med Life. 2018 Oct-Dec;11(4):293-298. doi: 10.25122/jml-2019-0002.
2
2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.2008年日本透析治疗学会:慢性肾脏病肾性贫血指南
Ther Apher Dial. 2010 Jun;14(3):240-75. doi: 10.1111/j.1744-9987.2010.00836.x.
3
Serum Hepcidin and Iron Indices Affect Anemia Status Differently According to the Kidney Function of Non-Dialysis Chronic Kidney Disease Patients: Korean Cohort Study For Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).血清铁调素和铁指标根据非透析慢性肾脏病患者的肾功能对贫血状态的影响不同:韩国慢性肾脏病患者结局研究(KNOW-CKD)。
Kidney Blood Press Res. 2017;42(6):1183-1192. doi: 10.1159/000485865. Epub 2017 Dec 8.
4
Low 1,25-dihydroxyvitamin D level is associated with erythropoietin deficiency and endogenous erythropoietin resistance in patients with chronic kidney disease.低水平的1,25-二羟维生素D与慢性肾脏病患者的促红细胞生成素缺乏及内源性促红细胞生成素抵抗相关。
Int Urol Nephrol. 2018 Dec;50(12):2255-2260. doi: 10.1007/s11255-018-1967-x. Epub 2018 Aug 22.
5
Low erythropoietin levels predict faster renal function decline in diabetic patients with anemia: a prospective cohort study.低红细胞生成素水平可预测伴贫血的糖尿病患者肾功能下降更快:一项前瞻性队列研究。
Sci Rep. 2019 Oct 16;9(1):14871. doi: 10.1038/s41598-019-51207-8.
6
Plasma neutrophil gelatinase-associated lipocalin is associated with iron status in anemic patients with pre-dialysis chronic kidney disease.血浆中性粒细胞明胶酶相关脂质运载蛋白与透析前慢性肾脏病贫血患者的铁状态相关。
Clin Exp Nephrol. 2018 Feb;22(1):28-34. doi: 10.1007/s10157-017-1409-6. Epub 2017 Apr 7.
7
Anemia Prevalence, Type, and Associated Risks in a Cohort of 5.0 Million Insured Patients in the United States by Level of Kidney Function.按肾功能水平评估美国 500 万参保患者的贫血患病率、类型及相关风险。
Am J Kidney Dis. 2023 Feb;81(2):201-209.e1. doi: 10.1053/j.ajkd.2022.07.014. Epub 2022 Sep 28.
8
Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients.氧化应激标志物在预测非透析慢性肾脏病患者对羧麦芽糖铁治疗的反应中的作用
Clin Nephrol. 2014 Jun;81(6):419-26. doi: 10.5414/CN108166.
9
Early response to erythropoiesis-stimulating agents in non-dialysis chronic kidney disease patients.非透析慢性肾脏病患者对促红细胞生成素刺激剂的早期反应
Clin Exp Nephrol. 2016 Aug;20(4):585-594. doi: 10.1007/s10157-015-1188-x. Epub 2015 Oct 28.
10
Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.慢性肾脏病患儿的铁调素与促炎标志物:一项病例对照研究
Clin Nephrol. 2018 May;89(5):363-370. doi: 10.5414/CN109132.

引用本文的文献

1
Increased incidence of anemia in individuals with impaired fasting glucose: a cohort study.空腹血糖受损个体贫血发病率增加:一项队列研究。
Acta Diabetol. 2025 May 27. doi: 10.1007/s00592-025-02517-z.
2
Gut Dysbiosis and Its Role in the Anemia of Chronic Kidney Disease.肠道菌群失调及其在慢性肾脏病贫血中的作用。
Toxins (Basel). 2024 Nov 17;16(11):495. doi: 10.3390/toxins16110495.
3
Phase angle and extracellular water-to-total body water ratio estimated by bioelectrical impedance analysis are associated with levels of hemoglobin and hematocrit in patients with diabetes.

本文引用的文献

1
New options for the anemia of chronic kidney disease.慢性肾脏病贫血的新治疗选择。
Kidney Int Suppl (2011). 2017 Dec;7(3):157-163. doi: 10.1016/j.kisu.2017.09.002. Epub 2017 Nov 17.
2
Effects of Volume Overload and Current Techniques for the Assessment of Fluid Status in Patients with Renal Disease.肾脏疾病患者容量超负荷的影响及当前液体状态评估技术。
Blood Purif. 2018;46(1):34-47. doi: 10.1159/000487702. Epub 2018 Apr 12.
3
Iron deficiency across chronic kidney disease stages: Is there a reverse gender pattern?慢性肾脏病各阶段的缺铁情况:是否存在相反的性别模式?
通过生物电阻抗分析估算的相角和细胞外水与总体水比率与糖尿病患者的血红蛋白和血细胞比容水平相关。
Heliyon. 2023 Mar 21;9(4):e14724. doi: 10.1016/j.heliyon.2023.e14724. eCollection 2023 Apr.
4
Adverse Drug Reactions of Antihypertensives and Polymorphism Among Chronic Kidney Disease Patients.慢性肾脏病患者中抗高血压药物的不良反应及基因多态性
Front Pharmacol. 2022 Mar 14;13:848804. doi: 10.3389/fphar.2022.848804. eCollection 2022.
PLoS One. 2018 Jan 22;13(1):e0191541. doi: 10.1371/journal.pone.0191541. eCollection 2018.
4
Update on Anemia in ESRD and Earlier Stages of CKD: Core Curriculum 2018.慢性肾脏病早期和终末期肾病贫血更新:2018 年核心课程。
Am J Kidney Dis. 2018 Mar;71(3):423-435. doi: 10.1053/j.ajkd.2017.09.026. Epub 2018 Jan 11.
5
Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease.肾脏协会慢性肾脏病贫血临床实践指南。
BMC Nephrol. 2017 Nov 30;18(1):345. doi: 10.1186/s12882-017-0688-1.
6
Chronic Fluid Overload and Mortality in ESRD.终末期肾病中的慢性液体过载与死亡率
J Am Soc Nephrol. 2017 Aug;28(8):2491-2497. doi: 10.1681/ASN.2016121341. Epub 2017 May 4.
7
Prevalence of chronic kidney disease and its association with cardio-metabolic risk factors in the adult Romanian population: the PREDATORR study.罗马尼亚成年人群慢性肾脏病的患病率及其与心血管代谢危险因素的关联:PREDATORR研究
Int Urol Nephrol. 2015 Nov;47(11):1831-8. doi: 10.1007/s11255-015-1109-7. Epub 2015 Sep 16.
8
Prevalence of anemia in chronic kidney disease in the United States.美国慢性肾脏病患者贫血的患病率
PLoS One. 2014 Jan 2;9(1):e84943. doi: 10.1371/journal.pone.0084943. eCollection 2014.
9
Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease.容量超负荷与慢性肾脏病患者的心血管危险因素相关。
Kidney Int. 2014 Mar;85(3):703-9. doi: 10.1038/ki.2013.336. Epub 2013 Sep 11.
10
Mechanisms of anemia in CKD.慢性肾脏病相关贫血的发病机制。
J Am Soc Nephrol. 2012 Oct;23(10):1631-4. doi: 10.1681/ASN.2011111078. Epub 2012 Aug 30.